Exozymes Inc. 8-K Filing
Ticker: EXOZ · Form: 8-K · Filed: Mar 31, 2026 · CIK: 0002010788
| Field | Detail |
|---|---|
| Company | Exozymes Inc. (EXOZ) |
| Form Type | 8-K |
| Filed Date | Mar 31, 2026 |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Exozymes Inc. (ticker: EXOZ) to the SEC on Mar 31, 2026.
How long is this filing?
Exozymes Inc.'s 8-K filing is 1 pages with approximately 393 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 393 words · 2 min read · ~1 pages · Grade level 10.2 · Accepted 2026-03-31 06:12:00
Filing Documents
- form8-k.htm (8-K) — 36KB
- ex99-1.htm (EX-99.1) — 83KB
- ex99-1_001.jpg (GRAPHIC) — 229KB
- ex99-1_002.jpg (GRAPHIC) — 499KB
- ex99-1_003.jpg (GRAPHIC) — 232KB
- ex99-1_004.jpg (GRAPHIC) — 294KB
- ex99-1_005.jpg (GRAPHIC) — 243KB
- ex99-1_006.jpg (GRAPHIC) — 263KB
- ex99-1_007.jpg (GRAPHIC) — 268KB
- ex99-1_008.jpg (GRAPHIC) — 243KB
- ex99-1_009.jpg (GRAPHIC) — 227KB
- ex99-1_010.jpg (GRAPHIC) — 299KB
- ex99-1_011.jpg (GRAPHIC) — 302KB
- ex99-1_012.jpg (GRAPHIC) — 333KB
- ex99-1_013.jpg (GRAPHIC) — 262KB
- ex99-1_014.jpg (GRAPHIC) — 188KB
- ex99-1_015.jpg (GRAPHIC) — 285KB
- ex99-1_016.jpg (GRAPHIC) — 288KB
- ex99-1_017.jpg (GRAPHIC) — 185KB
- ex99-1_018.jpg (GRAPHIC) — 283KB
- ex99-1_019.jpg (GRAPHIC) — 207KB
- ex99-1_020.jpg (GRAPHIC) — 55KB
- ex99-1_021.jpg (GRAPHIC) — 358KB
- ex99-1_022.jpg (GRAPHIC) — 250KB
- ex99-1_023.jpg (GRAPHIC) — 187KB
- ex99-1_024.jpg (GRAPHIC) — 318KB
- ex99-1_025.jpg (GRAPHIC) — 255KB
- ex99-1_026.jpg (GRAPHIC) — 278KB
- ex99-1_027.jpg (GRAPHIC) — 280KB
- ex99-1_028.jpg (GRAPHIC) — 307KB
- ex99-1_029.jpg (GRAPHIC) — 244KB
- ex99-1_030.jpg (GRAPHIC) — 274KB
- ex99-1_031.jpg (GRAPHIC) — 109KB
- ex99-1_032.jpg (GRAPHIC) — 139KB
- ex99-1_033.jpg (GRAPHIC) — 290KB
- ex99-1_034.jpg (GRAPHIC) — 199KB
- ex99-1_035.jpg (GRAPHIC) — 208KB
- ex99-1_036.jpg (GRAPHIC) — 131KB
- ex99-1_037.jpg (GRAPHIC) — 216KB
- ex99-1_038.jpg (GRAPHIC) — 183KB
- ex99-1_039.jpg (GRAPHIC) — 196KB
- ex99-1_040.jpg (GRAPHIC) — 337KB
- ex99-1_041.jpg (GRAPHIC) — 54KB
- ex99-1_042.jpg (GRAPHIC) — 543KB
- ex99-1_043.jpg (GRAPHIC) — 552KB
- ex99-1_044.jpg (GRAPHIC) — 89KB
- ex99-1_045.jpg (GRAPHIC) — 180KB
- ex99-1_046.jpg (GRAPHIC) — 230KB
- ex99-1_047.jpg (GRAPHIC) — 491KB
- ex99-1_048.jpg (GRAPHIC) — 156KB
- ex99-1_049.jpg (GRAPHIC) — 167KB
- ex99-1_050.jpg (GRAPHIC) — 147KB
- ex99-1_051.jpg (GRAPHIC) — 286KB
- ex99-1_052.jpg (GRAPHIC) — 212KB
- ex99-1_053.jpg (GRAPHIC) — 148KB
- ex99-1_054.jpg (GRAPHIC) — 527KB
- ex99-1_055.jpg (GRAPHIC) — 148KB
- ex99-1_056.jpg (GRAPHIC) — 157KB
- ex99-1_057.jpg (GRAPHIC) — 48KB
- ex99-1_058.jpg (GRAPHIC) — 499KB
- ex99-1_059.jpg (GRAPHIC) — 337KB
- ex99-1_060.jpg (GRAPHIC) — 295KB
- ex99-1_061.jpg (GRAPHIC) — 484KB
- ex99-1_062.jpg (GRAPHIC) — 70KB
- ex99-1_063.jpg (GRAPHIC) — 59KB
- ex99-1_064.jpg (GRAPHIC) — 163KB
- ex99-1_065.jpg (GRAPHIC) — 573KB
- ex99-1_066.jpg (GRAPHIC) — 72KB
- ex99-1_067.jpg (GRAPHIC) — 442KB
- ex99-1_068.jpg (GRAPHIC) — 384KB
- ex99-1_069.jpg (GRAPHIC) — 449KB
- ex99-1_070.jpg (GRAPHIC) — 482KB
- ex99-1_071.jpg (GRAPHIC) — 468KB
- ex99-1_072.jpg (GRAPHIC) — 134KB
- ex99-1_073.jpg (GRAPHIC) — 328KB
- ex99-1_074.jpg (GRAPHIC) — 458KB
- ex99-1_075.jpg (GRAPHIC) — 512KB
- ex99-1_076.jpg (GRAPHIC) — 430KB
- ex99-1_077.jpg (GRAPHIC) — 450KB
- ex99-1_078.jpg (GRAPHIC) — 237KB
- 0001493152-26-013733.txt ( ) — 29775KB
- exoz-20260330.xsd (EX-101.SCH) — 3KB
- exoz-20260330_lab.xml (EX-101.LAB) — 33KB
- exoz-20260330_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
01 — Other Events
Item 8.01 — Other Events. Attached is an updated Investor Presentation of eXoZymes Inc., a Nevada corporation, as of March 30, 2026, in connection with its NCTx business.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibits Description of Exhibit 99.1 Investor Presentation of eXoZymes Inc. for NCTx as of March 30, 2026. 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: March 30, 2026 EXOZYMES INC. By /s/ Fouad Nawaz Fouad Nawaz, Vice President, Finance